Abvc Biopharma annual capital expenditures (capex)
2010
2011
2012
2013
2021
2022
2023
Abvc Biopharma Capital Expenditures (CapEx) Growth & History (ABVC)
Abvc Biopharma's capital expenditures (capex) was $21,201 for fiscal 2023.
View full Abvc Biopharma company overviewAbvc Biopharma annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $21,201 | −$98,491 | −82.29% |
| 2022 | 2022-12-31 | $119,692 | $102,189 | +583.84% |
| 2021 | 2021-12-31 | $17,503 | — | — |
| 2013 | 2013-09-30 | $0 | −$350 | — |
| 2012 | 2012-09-30 | $350 | −$29,467 | −98.83% |
| 2011 | 2011-09-30 | $29,817 | $28,417 | +2029.79% |
| 2010 | 2010-09-30 | $1,400 | — | — |
Abvc Biopharma quarterly capital expenditures (capex)
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.22
Q2.22
Q3.22
Q4.22
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2022 | 2022-12-31 | $89 | — | — |
| Q3 2022 | 2022-09-30 | $4,357 | — | — |
| Q2 2022 | 2022-06-30 | $22,026 | — | — |
| Q1 2022 | 2022-03-31 | $93,220 | — | — |
| Q4 2013 | 2013-09-30 | $0 | $0 | — |
| Q3 2013 | 2013-06-30 | $0 | $0 | — |
| Q2 2013 | 2013-03-31 | $0 | $0 | — |
| Q1 2013 | 2012-12-31 | $0 | −$350 | — |
| Q4 2012 | 2012-09-30 | $0 | −$24,877 | — |
| Q3 2012 | 2012-06-30 | $0 | −$2,955 | — |
| Q2 2012 | 2012-03-31 | $0 | −$755 | — |
| Q1 2012 | 2011-12-31 | $350 | −$880 | −71.54% |
| Q4 2011 | 2011-09-30 | $24,877 | — | — |
| Q3 2011 | 2011-06-30 | $2,955 | — | — |
| Q2 2011 | 2011-03-31 | $755 | — | — |
| Q1 2011 | 2010-12-31 | $1,230 | — | — |
Abvc Biopharma capital expenditures (capex) trends
Between the periods ended 2010-09-30 and 2023-12-31, Abvc Biopharma's capital expenditures (capex) increased from $1,400 to $21,201, a change of $19,801. The latest reported quarter, Q4 2022, shows $89.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abvc Biopharma source filings ↗